Skip to main content
NACFC 2026 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Recorded Session
Recorded Session
Livestreamed Session
Livestreamed Session
Session is Ticketed (Add-on Session through Registration)
Session is Ticketed (Add-on Session through Registration)
Food Available for Session Attendees
Food Available for Session Attendees
Session includes an in person invitee/speaker with CF
Session includes an in person invitee/speaker with CF

Workshop

PHARM

W25-- Turning Up the Heat: Spicy Topics in CF Pharmacotherapy

Friday, October 9, 2026
10:15 AM - 12:15 PM EDT
What's heating up in Cystic Fibrosis pharmacy practice? This session will turn up the heat on emerging research and evolving perspectives in CF care. Topics include ETI use in special populations, hearing abnormalities related to ototoxic therapies, innovative pharmacist-led care models, provider perspectives on pharmacist contributions, and psychosocial outcomes in people with CF. Attendees will gain fresh perspectives on issues currently heating up the CF community.

Presentation Order:



1. The Impact of Vanzacaftor/Tezacaftor/Deutivacaftor on Parent-Perceived Psychosocial Functioning in People with Cystic Fibrosis: A Multi-Center Experience – Presented by Ashley Severin

2. Feasibility of a Pharmacist-Led Virtual Care Pathway to Provide Timely Cystic Fibrosis Pulmonary Exacerbation Management for Adults – Presented by Holly Jackson

3. CF-HEAR: Rates of Hearing and Vestibular Abnormalities in People With Cystic Fibrosis Exposed to Ototoxic Therapies – Presented by Cameron McKinzie

4. Perspectives of Medical Providers and Pharmacists Regarding Pharmacist Contributions to Cystic Fibrosis Outpatient Care – Presented by Lauren Kormelink

5. Elexacaftor/Tezacaftor/Ivacaftor Use Prenatally and in PwCF Less Than Two Years of Age – Presented by Wendy Bullington